BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 16705731)

  • 1. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
    Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD
    J Surg Oncol; 2006 Jun; 93(7):559-63. PubMed ID: 16705731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
    Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
    Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
    Han JS; Molberg KH; Sarode V
    Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of invasive breast cancer in mammographically detected microcalcification in patients with a core biopsy diagnosis of flat epithelial atypia, atypical ductal hyperplasia or ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy.
    Catteau X; Simon P; Noël JC
    Pathol Res Pract; 2012 Apr; 208(4):217-20. PubMed ID: 22445178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
    Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
    J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?
    Doyle B; Al-Mudhaffer M; Kennedy MM; O'Doherty A; Flanagan F; McDermott EW; Kerin MJ; Hill AD; Quinn CM
    J Clin Pathol; 2009 Jun; 62(6):534-8. PubMed ID: 19190009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice.
    Dillon MF; Quinn CM; McDermott EW; O'Doherty A; O'Higgins N; Hill AD
    J Clin Pathol; 2006 Jul; 59(7):740-3. PubMed ID: 16803949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.
    King TA; Farr GH; Cederbom GJ; Smetherman DH; Bolton JS; Stolier AJ; Fuhrman GM
    Am Surg; 2001 Sep; 67(9):907-12. PubMed ID: 11565774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
    Maeda H; Hayashida T; Watanuki R; Kikuchi M; Nakashoji A; Yokoe T; Seki T; Takahashi M; Kitagawa Y
    Breast Cancer; 2021 Mar; 28(2):398-404. PubMed ID: 33200381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
    Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
    Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive factors of invasion with initial diagnosis of ductal carcinoma in situ based on core biopsy].
    Kósa C; Garami Z; Dinya T; Fülöp B
    Magy Seb; 2012 Aug; 65(4):218-21. PubMed ID: 22940391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
    Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E
    Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
    Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
    Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of invasive breast cancer in ductal carcinoma in situ initially diagnosed by core biopsy.
    Chan MY; Lim S
    Asian J Surg; 2010 Apr; 33(2):76-82. PubMed ID: 21029943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
    Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
    Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.
    Trentin C; Dominelli V; Maisonneuve P; Menna S; Bazolli B; Luini A; Cassano E
    Breast; 2012 Oct; 21(5):635-40. PubMed ID: 22795363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
    Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
    J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus.
    Wahedna Y; Evans AJ; Pinder SE; Ellis IO; Blamey RW; Geraghty JG
    Eur J Cancer; 2001 Mar; 37(4):459-62. PubMed ID: 11267854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.
    Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA
    J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.